Leafwell, a platform specializing in employer-sponsored medical cannabis, is advocating for the recognition of medical cannabis as a viable alternative to costly traditional treatments for conditions like cancer, chronic pain, and sleep disorders. With over 700,000 patients served and solid peer-reviewed evidence, Leafwell offers telehealth consultations, personalized treatment plans, and ongoing support aimed at improving health outcomes while potentially lowering healthcare costs. Emily Fisher, Leafwell’s founder and a two-time breast cancer survivor, emphasizes the connection between physical and emotional health, particularly for those dealing with serious illnesses.

This approach could be significant for people looking to manage chronic conditions more effectively. Research indicates that patients using medically certified cannabis experienced a 35% reduction in emergency department visits. Additionally, the adoption of medical cannabis programs could save U.S. employers around $29 billion annually, making it an attractive option for both employees and employers facing rising healthcare costs.

The research supporting these claims is backed by peer-reviewed studies, but it’s important to note that while the evidence is promising, it is still in the early stages of broader acceptance in mainstream healthcare. Leafwell is working to establish a robust infrastructure that demonstrates how physician-guided cannabis therapy can help employees feel better, maintain productivity, and potentially avoid more expensive treatment options.

If you are considering medical cannabis as part of your health management strategy, it may be worth discussing with your healthcare provider to explore personalized options that align with your needs and circumstances.

Source: globenewswire.com